Pratte Eli L, Cho Junsang, Landreneau James R, Hirabayashi Matthew T, An Jella A
University of Missouri School of Medicine, Columbia, MO, USA.
Department of Ophthalmology, University of Missouri School of Medicine, Columbia, MO, USA; Mason Eye Institute East, Columbia, MO, USA.
J Curr Glaucoma Pract. 2022 Jan-Apr;16(1):47-52. doi: 10.5005/jp-journals-10078-1313.
To identify factors that were significant predictors of Kahook Dual Blade (KDB) excisional goniotomy outcomes.
One hundred and thirty-two eyes from 99 adult glaucoma patients who underwent combined KDB and phacoemulsification (KDB-phaco) with a minimum 6-month follow-up were assessed for baseline patient characteristics to determine correlation to the success of KDB-phaco at 6 and 12 months postoperatively. Success was defined as ≥20% intraocular pressure (IOP) reduction or ≥1 medication reduction as well as IOP ≤18 mm Hg without any additional IOP-lowering procedures after KDB-phaco.
63.6% (84/132) and 46.1% (41/89) of cases were successful at the 6- and 12-month follow-ups, respectively. KDB-phaco reduced patient's preoperative IOP (in mm Hg) from 17.6 ± 4.6 to 14.9 ± 3.2 at 6 months (15.3%, < 0.001) and 15.4 ± 4.7 at 12 months (12.5%, = 0.001). KDB-phaco reduced patient's preoperative IOP-lowering medications from 2 ± 1.2 to 1.1 ± 1.2 at 6 months (45%, < 0.001) and 1.32 ± 1.3 at 12 months (34%, < 0.001). At 6 months, patients on >1 IOP lowering medication had a greater chance of meeting our success criteria ( = 0.037). Visually significant postoperative hyphema was not associated with the use of anticoagulation ( = 0.943) but was significantly associated with postoperative day 1 IOP ≤ 10 mm Hg ( = 0.011).
Patients who underwent KDB-phaco significantly reduced their IOP and medication burden at both 6 and 12 months compared with their baseline preoperative values. KDB-phaco outcome was associated with higher baseline IOP-lowering medications and increased rate of hyphema was associated with lower postoperative day 1 IOP, regardless of anticoagulation status. Age, ethnicity, prior laser trabeculoplasty, type and severity of glaucoma, and baseline preoperative IOP were not associated with surgical success.
Patients with a higher number of baseline medications may experience a greater probability of success following KDB-phaco.
Pratte EL, Cho J, Landreneau JR, Predictive Factors of Outcomes in Kahook Dual Blade Excisional Goniotomy Combined with Phacoemulsification. J Curr Glaucoma Pract 2022;16(1):47-52.
确定影响卡胡克双刃刀(KDB)切除性房角切开术效果的显著预测因素。
对99例接受KDB联合超声乳化术(KDB-超声乳化术)且至少随访6个月的成年青光眼患者的132只眼睛进行评估,分析患者基线特征与术后6个月和12个月KDB-超声乳化术成功率的相关性。成功定义为眼压(IOP)降低≥20%或减少≥1种降眼压药物,且KDB-超声乳化术后无需任何额外降眼压措施时眼压≤18mmHg。
在6个月和12个月随访时,分别有63.6%(84/132)和46.1%(41/89)的病例成功。KDB-超声乳化术使患者术前眼压(mmHg)在6个月时从17.6±4.6降至14.9±3.2(降低15.3%,P<0.001),在12个月时降至15.4±4.7(降低12.5%,P=0.001)。KDB-超声乳化术使患者术前降眼压药物从2±1.2种降至6个月时的1.1±1.2种(降低45%,P<0.001),12个月时降至1.32±1.3种(降低34%,P<0.001)。在6个月时,使用超过1种降眼压药物的患者更有可能达到成功标准(P=0.037)。具有视觉意义的术后前房积血与抗凝药物的使用无关(P=0.943),但与术后第1天眼压≤10mmHg显著相关(P=0.011)。
与术前基线值相比,接受KDB-超声乳化术的患者在6个月和12个月时眼压和药物负担均显著降低。KDB-超声乳化术的效果与较高的基线降眼压药物使用量相关,前房积血发生率增加与术后第1天较低的眼压相关,与抗凝状态无关。年龄、种族、既往激光小梁成形术、青光眼类型和严重程度以及术前基线眼压与手术成功率无关。
基线使用药物数量较多的患者在KDB-超声乳化术后成功的可能性可能更大。
普拉特EL、赵J杰、兰德雷诺JR,卡胡克双刃刀切除性房角切开术联合超声乳化术效果的预测因素。《当代青光眼实践杂志》2022年;16(1):47-52。